Taiwan Liposome Company Ltd ADR (TLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 398 | 597 | 605 | 663 | 5,127 |
| Gross Profit | 398 | 597 | 605 | 663 | 5,127 |
| Operating Expenses | 7,435 | 10,213 | 6,360 | 8,447 | 8,773 |
| Operating Income | -7,037 | -9,616 | -5,755 | -7,784 | -3,645 |
| Interest Expense | 146 | 189 | 196 | 207 | 199 |
| Other Income | 73 | 36 | 227 | 243 | 224 |
| Pre-tax Income | -7,110 | -9,769 | -5,724 | -7,748 | -3,621 |
| Income Tax | 14 | 98 | 4 | 28 | 9 |
| Net Income Continuous | -7,124 | -9,866 | -5,727 | -7,776 | -3,630 |
| Net Income | $-7,124 | $-9,866 | $-5,727 | $-7,776 | $-3,630 |
| EPS Basic Total Ops | -0.19 | -0.28 | -0.18 | -0.24 | -0.11 |
| EPS Basic Continuous Ops | -0.22 | -0.29 | -0.18 | -0.24 | -0.11 |
| EPS Diluted Total Ops | -0.19 | -0.28 | -0.18 | -0.24 | -0.11 |
| EPS Diluted Continuous Ops | -0.22 | -0.29 | -0.18 | -0.24 | -0.11 |
| EPS Diluted Before Non-Recurring Items | -0.10 | -0.28 | -0.09 | N/A | N/A |
| EBITDA(a) | $-6,522 | $-9,008 | $-5,207 | $-7,221 | $-2,978 |